<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00120432</url>
  </required_header>
  <id_info>
    <org_study_id>HE461104</org_study_id>
    <nct_id>NCT00120432</nct_id>
  </id_info>
  <brief_title>Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation</brief_title>
  <official_title>Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Khon Kaen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Khon Kaen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy on pupillary dilation between the single
      dose versus the three doses of 1% tropicamide with 10% phenylephrine for complete ocular
      examination.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To the best of the authors' knowledge, there have been no clinical trials using an
      appropriate regimen for pupillary dilation up until now. Therefore, the authors were
      interested to find out the most appropriate regimen for complete ocular examination, based on
      the finding that a pupil diameter of 6 mm or greater is adequate for indirect ophthalmoscopy.
      The authors hypothesize that a single dose of 1% tropicamide and 10% phenylephrine is
      adequate to complete the job and are conducting this prospective randomized clinical
      controlled trial to prove the hypothesis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">June 2005</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>horizontal pupil diameter</measure>
    <time_frame>30 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>systolic blood pressure</measure>
    <time_frame>30 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diastolic blood pressure</measure>
    <time_frame>30 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>30 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse drug reaction</measure>
    <time_frame>30 min</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Eye Diseases</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>single dose vs three doses of 1%tropicamide and 10%phenylephrine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1% tropicamide and 10% phenylephrine</intervention_name>
    <description>single dose vs three doses of 1%tropicamide and 10%phenylephrine</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged between 20 and 80 years old

          -  dark iris

          -  require binocular indirect ophthalmoscopy for complete ocular examination

          -  signed written consent forms

        Exclusion Criteria:

          -  history of ocular trauma

          -  history of intraocular surgery

          -  history of laser treatment

          -  previous eye drop instillation that may affect pupillary dilation

          -  ocular diseases that may affect pupil size such as Horner's syndrome, Adies' pupil,
             glaucoma and uveitis

          -  history of diabetes mellitus, severe hypertension and cardiovascular diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yosanan Yospaiboon, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Khon Kaen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Srinagarind Hospital</name>
      <address>
        <city>Khon Kaen</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <results_reference>
    <citation>Ratanapakorn T, Yospaiboon Y, Chaisrisawadsuk N. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation. J Med Assoc Thai. 2006 Nov;89(11):1934-9.</citation>
    <PMID>17205877</PMID>
  </results_reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2005</study_first_submitted>
  <study_first_submitted_qc>July 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2005</study_first_posted>
  <last_update_submitted>March 7, 2012</last_update_submitted>
  <last_update_submitted_qc>March 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Khon Kaen University</investigator_affiliation>
    <investigator_full_name>Yosanan Yospaiboon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>single dose</keyword>
  <keyword>mydriatic drug</keyword>
  <keyword>pupillary dilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Diseases</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
    <mesh_term>Mydriasis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Tropicamide</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

